TECN Tecan Group AG

SWX · CH · Healthcare · Medical Instruments & Supplies · tecan.com

243.60CHF+5.36%Mkt Cap: 3.43B $P/E: —Today

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Busi…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

$49.21BUSDP/E 42.0

MDLN

Medline Inc. - Class A common stock

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc. - Common Stock

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

Key Statistics

Company

Market Cap3.43B USD

Enterprise Value3.24B USD

Revenue (TTM)993.54M USD

Gross Profit354.76M USD

Net Income (TTM)-126.29M USD

Revenue/Share69.62 CHF

Last Price243.60 CHF

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees3.0K

CountryCH

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)29.63

PEG1.71

EV/EBITDA38.80

EV/Revenue3.26

P/S3.27

P/B2.55

EPS (TTM)-9.16

EPS (Forward)7.80

52W Range

110.6096% of range248.60

52W High248.60 CHF

52W Low110.60 CHF

Profitability

Gross Margin35.22%

Oper. Margin4.16%

EBITDA Margin8.40%

Profit Margin-12.54%

ROE-9.61%

ROA-6.52%

Growth

Revenue Growth-2.70%

Earnings Growth-29.80%

Cash Flow & Leverage

Operating CF157.47M USD

CapEx (TTM)40.29M USD

FCF Margin5.53%

FCF Yield1.60%

Net Debt-11.60M USD

Net Debt/EBITDA-0.14

Balance Sheet

Debt/Equity0.19

Current Ratio2.32

Quick Ratio1.50

Book Value/Sh90.71 CHF

Cash/Share18.22 CHF

Dividends

Fwd Div Rate3.00 CHF

Trail. Div Rate3.00 CHF

Div. Yield1.30%

5Y Avg Yield0.97%

Payout Ratio60.61%

Ex-Div DateApr 17, 2026

Pay DateApr 16, 2025

Analyst Consensus

Rating2.4 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)195.72 CHF

Upside (mean)-19.7%

Target Range160.80 CHF – 255.00 CHF

160.80-19.7% to mean255.00

# Analysts8

Ownership

Shares Out.12.32M

Float12.27M

Insiders0.43%

Institutions66.76%

Technical

SMA 50201.05 (+21.2%)

SMA 200157.11 (+55.1%)

Beta1.08

S&P 52W Chg14.58%

Avg Vol (30d)64.55K

Avg Vol (10d)77.84K

Technical Indicators

RSI (14)68.3

MACD10.1365

MACD Signal8.9833

MACD Hist.+1.1532

BB Upper243.02 CHF

BB Middle215.27 CHF

BB Lower187.52 CHF

BB Width25.78%

ATR (14)6.569 CHF

Vol Ratio (20d)0.94x